Zhuhai HRD Pharmaceutical Co., Ltd. was established in 2009. We are a modern company engaged in the research and development, production and sales of pharmaceutical APIs and intermediates. Zhuhai HRD invested 250 million yuan in April 2019 to start the construction of a new GMP production in , with a total of 6 production workshops and supporting facilities built according to API standards and will be completed and put into production in the first half of 2023. It is estimated that the annual production capacity is 300 tons, and the output value is 1 billion yuan.
National chemical Park: Complete utility systems and stable supply.
Scale: There is 6 GMP workshops which Covers an area of about 40000 square meters, more than 200 stainless steel and enamel reactors which capacity range from 100L to 6000L, the reactors are suitable for kg to 100kg production, meet the requirements of pilot test and scale up.
R&D: We have independent research and development team, good at Grignell reaction, hydrogenation reaction, ultra-low temperature reaction (-80°C), can independently conduct quality research and registration of API.
Product list of API and its intermediates: Oseltamivir phosphate, Tedizolid Phosphate, Vonoprazan Fumarate, Edoxaban, Edoxaban (tosylate Monohydrate), Relugolix, Elagolix Sodium, Ilaprazole, Finerenone, Fluvoxamine maleate and so on.